Screening for colorectal carcinoma
- PMID: 20404976
- PMCID: PMC2854634
- DOI: 10.3747/co.v17i2.602
Screening for colorectal carcinoma
Abstract
Colorectal carcinoma is the second most common cause of death in Canada. Because there is a precursor lesion (that is, the polyp), screening is critically important to prevent the disease through polyp removal-and failing that, to detect colorectal carcinoma at an early stage, when it can be cured. Several screening modalities are available, but colonoscopy is considered the best. People should avail themselves of such examinations, and physicians should encourage them to do so.
Keywords: Screening; colorectal cancer.
References
-
- Canadian Cancer Society and the National Cancer Institute of Canada . Canadian Cancer Statistics 2009. Toronto: Canadian Cancer Society; 2009.
-
- Ellul P, Fogden E, Simpson CL. Downstaging of colorectal cancer by the National Bowel Cancer Screening Programme in England: first round data from the first centre. Colorectal Dis. 2009 [Epub ahead of print] - PubMed
-
- Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71. [Erratum in: N Engl J Med 1993;329:672] - PubMed
-
- Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–18. - PubMed
-
- Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71. - PubMed
LinkOut - more resources
Full Text Sources
